Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
70% TCA for Atrophic Varicella Scars
NCT00422539Phase 2Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2006
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of trichloroacetic acid in atrophic varicella scar, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Objective Clearance. Status: unknown.
02
Drugs
trichloroacetic acid
03
Conditions
atrophic varicella scar
Beyond the preview
Go deeper on NCT00422539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00422539.